Supplement Figure S-12 from A Phase Ib Study of Chemoimmunotherapy with Pegylated Liposomal Doxorubicin and Pembrolizumab in Estrogen Receptor–Positive Metastatic Breast Cancer
Authors:Alberto A. Gabizon, Hadar Goldvaser, Adar Yaacov et al.
Prevalence and determinants of Skilled Birth Attendance Among Women Who Delivered in the Past 12 Months in Sene East District, Ghana: A Community-Based Cross-Sectional Study
Maxwell Adjiabadek Akesem, Daniel Ankomah et al. - Unknown
Data from A Phase Ib Study of Chemoimmunotherapy with Pegylated Liposomal Doxorubicin and Pembrolizumab in Estrogen Receptor–Positive Metastatic Breast Cancer
Alberto A. Gabizon, Hadar Goldvaser et al. - Unknown
Table 2 from A Phase Ib Study of Chemoimmunotherapy with Pegylated Liposomal Doxorubicin and Pembrolizumab in Estrogen Receptor–Positive Metastatic Breast Cancer
Alberto A. Gabizon, Hadar Goldvaser et al. - Unknown